Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-12 5:28 pm Purchase |
2022-07-29 | 13G | 89bio, Inc. ETNB |
ADAGE CAPITAL PARTNERS GP LLC | 2,690,000 6.800% |
2,690,000 (New Position) |
Filing History |
| 2022-07-11 5:03 pm Purchase |
2022-06-29 | 13G | 89bio, Inc. ETNB |
BIOTECHNOLOGY VALUE FUND L P | 3,898,000 9.990% |
3,898,000 (New Position) |
Filing History |
| 2022-07-08 5:13 pm Purchase |
2022-06-29 | 13G | 89bio, Inc. ETNB |
GREAT POINT PARTNERS LLC | 2,100,000 5.290% |
2,100,000 (New Position) |
Filing History |
| 2022-07-07 09:24 am Purchase |
2022-06-29 | 13G | 89bio, Inc. ETNB |
Deep Track Capital, LP | 4,331,499 9.990% |
4,331,499 (New Position) |
Filing History |
| 2022-07-06 5:25 pm Purchase |
2009-02-28 | 13D | 89bio, Inc. ETNB |
RA Capital Management, L.P. | 7,806,169 19.900% |
2,840,400 (+57.20%) |
Filing History |
| 2022-07-05 4:30 pm Sale |
2022-07-05 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 1,829,436 4.700% |
-35,285 (-1.89%) |
Filing History |
| 2022-06-10 10:14 am Sale |
2022-05-31 | 13G | 89bio, Inc. ETNB |
WELLINGTON MANAGEMENT CO LLP | 0 0.000% |
-2,150,475 (Position Closed) |
Filing History |
| 2022-02-14 06:11 am Sale |
2021-12-31 | 13G | 89bio, Inc. ETNB |
Nussbaum Ran | 827,701 4.100% |
-194,753 (-19.05%) |
Filing History |
| 2022-02-07 5:15 pm Sale |
2022-01-27 | 13D | 89bio, Inc. ETNB |
Longitude Capital Partners III LLC | 1,222,733 6.000% |
-531,117 (-30.28%) |
Filing History |
| 2022-01-10 08:37 am Purchase |
2021-12-31 | 13G | 89bio, Inc. ETNB |
WELLINGTON MANAGEMENT CO LLP | 2,150,475 10.600% |
885,564 (+70.01%) |
Filing History |
| 2021-06-04 4:32 pm Purchase |
2009-02-28 | 13D | 89bio, Inc. ETNB |
RA Capital Management, L.P. | 4,965,769 24.800% |
229,555 (+4.85%) |
Filing History |
| 2021-02-09 10:20 am Sale |
2020-12-31 | 13G | 89bio, Inc. ETNB |
Nussbaum Ran | 1,022,454 5.100% |
-112,217 (-9.89%) |
Filing History |
| 2021-02-04 11:19 am Purchase |
2020-12-31 | 13G | 89bio, Inc. ETNB |
WELLINGTON MANAGEMENT CO LLP | 1,264,911 6.360% |
341,912 (+37.04%) |
Filing History |
| 2020-11-25 4:32 pm Sale |
2020-11-16 | 13D | 89bio, Inc. ETNB |
Longitude Capital Partners III LLC | 1,753,850 8.800% |
-847,027 (-32.57%) |
Filing History |
| 2020-09-23 5:00 pm Sale |
2020-09-21 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 1,864,721 9.400% |
-137,500 (-6.87%) |
Filing History |
| 2020-09-21 5:24 pm Purchase |
2009-02-28 | 13D | 89bio, Inc. ETNB |
RA Capital Management, L.P. | 4,736,214 23.800% |
1,300,000 (+37.83%) |
Filing History |
| 2020-07-20 5:00 pm Purchase |
2020-07-10 | 13D | 89bio, Inc. ETNB |
Longitude Capital Partners III LLC | 2,600,877 15.400% |
109,090 (+4.38%) |
Filing History |
| 2020-07-13 4:20 pm Unchanged |
2020-07-10 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 2,002,221 11.900% |
0 (Unchanged) |
Filing History |
| 2020-07-10 4:30 pm Purchase |
2009-02-28 | 13D | 89bio, Inc. ETNB |
RA Capital Management, L.P. | 3,436,214 20.400% |
275,000 (+8.70%) |
Filing History |